This topic contains a solution. Click here to go to the answer

Author Question: The deadweight loss from a monopoly refers to a. the portion of a monopolist's profits that are ... (Read 44 times)

jwb375

  • Hero Member
  • *****
  • Posts: 540
The deadweight loss from a monopoly refers to
 a. the portion of a monopolist's profits that are above the competitive profit level.
  b. the increase in price due to the monopolization of a market.
  c. the inefficient use of factors of production by a monopoly.
  d. the loss of consumer surplus due to the monopolization of a market that is not transferred to another economic actor.

Question 2

If a monopoly is maximizing profits,
 a. price will always be greater than the elasticity of demand.
  b. price will always equal marginal cost.
  c. price will always be greater than marginal cost.
  d. price will always equal marginal revenue.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

dpost18

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

d

Answer to Question 2

c




jwb375

  • Member
  • Posts: 540
Reply 2 on: Jul 1, 2018
:D TYSM


pangili4

  • Member
  • Posts: 346
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Most childhood vaccines are 90–99% effective in preventing disease. Side effects are rarely serious.

Did you know?

As many as 20% of Americans have been infected by the fungus known as Histoplasmosis. While most people are asymptomatic or only have slight symptoms, infection can progress to a rapid and potentially fatal superinfection.

Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

Did you know?

Blastomycosis is often misdiagnosed, resulting in tragic outcomes. It is caused by a fungus living in moist soil, in wooded areas of the United States and Canada. If inhaled, the fungus can cause mild breathing problems that may worsen and cause serious illness and even death.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library